Although in vitro fertilization (IVF), one of the most effective and successful assisted reproductive technologies, is widely used for treating infertility and in animal breeding, increasing evidence indicates that IVF offspring are linked to various shortor long-term consequences. Erroneous epigenetic modifications induced by IVF are suspected of contributing to these consequences. Among these epigenetic modifications, microRNAs may affect embryo implantation and early postimplantation development. Here, we performed comparative microRNA profiling between in vivo-fertilized (IVO group) and in vitrofertilized (IVF group) mouse embryos at Embryonic Day 3.5 (E3.5) and E7.5. Our dynamic analyses showed that the dysregulated microRNAs were mainly associated with the regulation of genes involved in carcinogenesis, genetic information processing, glucose metabolism, cytoskeleton organization, and neurogenesis. Further analysis showed that miR-199a-5p was consistently downregulated in IVF embryos compared with their IVO counterparts. Through gain-and loss-of-function experiments, we demonstrated that IVF-induced downregulation of miR-199a-5p results in a higher glycolytic rate and lower developmental potential of IVF blastocysts, including cell lineage misallocation and lower fetal survival post implantation. Therefore, preventing downregulation of miR-199a-5p may become an effective strategy for improving the development of IVF peri-implantation embryos in the future. development, glycolysis, hexokinase 2, in vitro fertilization, microRNA sequencing, miR-199a-5p
INTRODUCTION
More than 5 million people have been born through in vitro fertilization (IVF) since the birth of the first IVF baby on 25
July 1978 [1] . This shows IVF is one of the most effective and successful assisted reproductive technologies routinely used for treating infertility that affects ;16% of couples globally [1] . Currently, IVF and other assisted reproduction technologies account for 1%-5% of all newborns in developed countries [1] . Fortunately, epidemiologic data show that IVF offspring are healthy; however, a slight but worrying increase in IVFassociated short-or long-term consequences, including pregnancy complications, preterm birth, low birth weight, birth defects, and imprinting disorders, is causing great concern [2] [3] [4] . In addition, animal studies warn that IVF offspring are associated with higher risk of age-related disorders, such as heart disease, diabetes, and hypertension [5] [6] [7] . Therefore, more investigation is required to determine these risks and improve the existing IVF system.
In vitro fertilization-induced erroneous epigenetic modifications are linked to these various short-or long-term consequences in IVF offspring [8] . During the process of IVF, both the gametes and the preimplantation embryo are exposed to laboratory conditions that do not perfectly recapitulate the normal environment of the fallopian tube and uterus [9, 10] . Notably, the artificial environment used during IVF coincides with the crucial developmental stages in which genome-wide epigenetic reprogramming occurs (i.e., fertilization itself and preimplantation development) [11, 12] . Thus, a suboptimal IVF physicochemical environment (e.g., inappropriate temperature and oxygen concentration) and the absence or insufficiency of factors (e.g., cytokines and hormones) may disturb the epigenetic reprogramming, thereby resulting in adverse outcomes of IVF offspring.
MicroRNAs (miRNAs) are short noncoding RNAs that repress protein translation and decrease mRNA stability [13] . The expression profile of miRNAs in preimplantation embryos undergoes dynamic changes [14, 15] . Although miRNAs appear to be nonessential during preimplantation embryonic development [16] , dysregulated miRNAs in preimplantation embryos are essential for embryo implantation and early postimplantation development [16] [17] [18] [19] . Therefore, miRNAs may be influenced by the IVF process, resulting in adverse postimplantation development and long-term side effects.
In this study, we investigated the role of miRNAs in IVF by using a mouse model. We carried out comparative miRNA profiling between mouse embryos produced by in vivo fertilization (IVO group) and IVF group at embryonic day 3.5 (E3.5) and E7.5. Furthermore, we examined the functional consequences of the IVF-induced downregulation of a particular miRNA, miR-199a-5p.
MATERIALS AND METHODS

Ethics
The protocols for the animal studies were approved by and performed in accordance with the requirements of the Institutional Animal Care and Use Committee of China Agricultural University, Beijing, China.
Institute for Cancer Research (ICR) female mice (6 weeks of age) and ICR male mice (8À10 wk of age) were used in the study. The mice were fed ad libitum and housed at 218C 6 18C under controlled lighting conditions (12L:12D).
Chemicals and Reagents
All chemicals and reagents used in the study were purchased from SigmaAldrich, unless otherwise specified.
Experimental Design
A previously described method [20] [21] [22] was used to test the effect of the IVF process on the miRNA expression profiles of early embryos (Fig. 1) . Briefly, IVF was chosen as an integrated technical treatment. After either in vivo fertilization and development (IVO group control) or in vitro fertilization and culture (IVF group), blastocysts were collected from both of the groups and transferred to pseudopregnant recipient mice. At E7.5, recipient females were euthanized, and embryos with normal morphology [23] were collected. The embryos collected at E3.5 and E7.5 were subsequently used for highthroughput miRNA sequencing. Due to the small quantities of RNA in each early embryo, a single pooling strategy was applied, as previously described [24, 25] . This pooling strategy is appropriate in experiments with low sample yields and can reduce biological variance, which in turn, may increase the power to detect changes [26] . Moreover, because IVF-induced disorders always display population characteristics, single pooling is a rational strategy to ensure a relatively large sample size that is representative of the population.
The blastocysts from the IVO and IVF groups were further used for molecular detection, quantitation of carbohydrate metabolism, and evaluation of developmental potential. In addition, pronuclear embryos from IVO and IVF groups were used for microinjection of a miR-199a-5p inhibitor or mimic to investigate the potential role of the candidate miRNA.
Embryo Preparation
All embryo preparation procedures were performed as previously described [27] , with minor modifications. ICR female mice were superovulated by i.p. injection of 5 IU of equine chorionic gonadotropin, followed 48 h later by i.p. injection of 5 IU of human chorionic gonadotropin (hCG). In the IVO group, superovulated females were caged individually with males after the hCG injection. The following morning, successful mating was confirmed by the presence of a vaginal plug. At 96-100 h post hCG, blastocysts were obtained from donor females by flushing the uterus with M2 medium. Only welldeveloped late-cavitating blastocysts of similar morphology, based on morphological landmarks established by Nagy et al. [27] , were selected for further analyses.
In the IVF group, sperm was collected from the cauda epididymis and capacitated for 1 h in human tubal fluid medium (Sage) covered with paraffin oil at 378C and 5% CO 2 . Oocytes were collected from the ampullae at 14 h post hCG treatment. Then, gametes were co-incubated in human tubal fluid medium for 4 h at 378C and 5% CO 2 . After 4 h in the incubator, zygotes were washed and cultured until the blastocyst stage in potassium simplex optimization medium containing amino acids (KSOMþAA; Millipore) at 378C in a 5% CO 2 incubator. Previous studies have reported that in vitro embryos show delayed preimplantation development [28] [29] [30] . Well-developed late-cavitating blastocysts of similar morphology, based on landmark established by Nagy et al. [27] , were sampled at 106-110 h post hCG.
Pseudopregnant female mice (recipients) were caged individually with vasectomized males for 3.5 days prior to embryo transfer. The morning after mating, the recipients were checked for the presence of a vaginal plug. The day of plugging was considered Day 0.5 of the pseudopregnancy. Blastocysts of similar morphology were selected for embryo transfer in each group. Twelve blastocysts were transferred to each recipient according to standard procedures [27] , with six embryos in each uterine horn.
Postimplantation Embryo Collection
The criteria for selecting embryos for pooling were based on typical morphological features according to well-established landmarks [31, 32] . In detail, at E7.5, well-developed embryos at the gastrulation stage were characterized by a sealed-off amniotic cavity and the formation of three distinct cavities (amniotic cavity, exocoelom, and ectoplacental cleft).
At E7.5, the conceptuses covered with the decidual mass were gently teased away from the uterus, the decidua in which the conceptus embedded was peeled off, and the parietal yolk sac was opened to expose the visceral yolk sac endoderm layer. The epiblast was separated from the extraembryonic tissues by using microdissecting watchmaker's forceps under a stereomicroscope. All sampled embryos used for RNA isolation were serially washed with phosphatebuffered saline (PBS; Gibco BRL, Grand Island, NY) and stored immediately in liquid nitrogen for further use.
To examine the midterm pregnancy status, implantation sites and embryos were isolated at E10.5, and recovered fetuses with a beating heart were defined as still alive.
MicroRNA Sequencing
Samples of small-sized RNA samples from IVO and IVF embryos were prepared for Sequencing by Oligonucleotide Ligation and Detection (SOLiD) sequencing as described previously [33] . Briefly, total RNA was extracted using Trizol reagent (Invitrogen) following the manufacturer's procedure and processed by using a flashPAGE fractionator (Ambion) and flashPAGE CleanUp kit (Ambion). The enriched small RNA was then processed according to the SOLiD small RNA expression kit protocol (Applied Biosystems). The purified small RNAs were ligated with the 5 0 and 3 0 adapter mixture using RNA ligase and reverse transcribed and purified using a Novex 10% Tris-borate-ethylene FIG. 1. Overview of experimental design. Blastocysts from in vivo fertilization and development (IVO) group and IVF and culture group were collected and transferred into pseudopregnant females. Both the IVO and IVF embryos were collected at E3.5, E7.5, and E10.5, respectively. E3.5 and E7.5 samples were used for total RNA extraction and miRNA sequencing, and E10.5 fetuses were collected for postimplantation development analyses.
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diamine tetraacetic acid (TBE)-urea gel (Invitrogen). Subsequently, 16 cycles of PCR were performed to amplify the purified cDNA with the barcoded PCR primer sets provided in the SOLiD kit. The amplified products were loaded on a Novex 6% TBE gel (Invitrogen), and the gel bands containing 110-to 130-bp fragments were excised. The amplified products were purified from the excised gel band, amplified by emulsion PCR, and then loaded onto the SOLiD 4 nextgeneration high-throughput sequencing system for data acquisition. The quality of the samples and libraries were verified by using the Bioanalyzer machine (Agilent) [34] .
The detected nucleotide sequences were compared with known miRNAs in the miRbase database (http://www.mirbase.org) to identify the miRNAs. To increase the power to detect biologically meaningful functions, 2-fold change (FC) and a P value of ,0.05 were used to filter the differentially expressed miRNAs for further biological analysis. The target genes of the differentially expressed miRNAs were predicted by using TargetScan (http://www. targetscan.org). The Kyoto Encyclopedia of Genes and Genomes (KEGG; http://www.genome.jp/kegg/) was used to determine the associated pathways.
Quantitative Real-Time PCR Analysis
Total RNA was isolated using Trizol reagent (Invitrogen), and RNA samples were digested with DNase I (Fermentas) to remove contaminating genomic DNA. The concentration and quality of the extracted total RNA were assessed by A260 nm:A280 nm and A260 nm:A230 nm ratios, determined using a DS-11 spectrophotometer (Denovix). An iScript cDNA synthesis kit (Bio-Rad) was used for reverse transcription according to the manufacturer's instruction. Real-time PCR was performed using SsoFast EvaGreen Supermix in a CFX96 real-time PCR system (Bio-Rad). Real-time PCR primer sequences were: Hk2, 5 0 -CCTGTTCTACTTCCTGTA-3 0 and 5 0 -AAGATGTTCTC CACCTAT-3 0 ; gapdh, 5 0 -TGCCCCCATGTTTGTGATG-3 0 and 5 0 -TGTGGTCATGAGCCCTTCC-3 0 ; and actb, 5 0 -AGGTCATCACTATTGG CAAC-3 0 and 5 0 -ACTCATCGTACTCCTGCTTG-3 0 . Data analysis based on measurements of the threshold cycle was performed using the 2
ÀDDCt method. For quantitative reverse-transcriptase PCR (qRT-PCR) analysis, 35-40 blastocysts were sampled in each group. At least three independent experiments were performed for each analysis.
We used stem-loop qRT-PCR to analyze miRNA expression as described previously [35] . Briefly, miRNA reverse transcription reactions were performed using the TaqMan miRNA reverse transcription kit (Applied Biosystems), using 10 ng of RNA and 3 ll of miRNA-specific RT-stem-loop primer (Applied Biosystems) according to the manufacturer's instruction. Real-time PCR analysis was carried out using TaqMan Universal Master Mix (Applied Biosystems). U6 was used as internal reference of miR-199a-5p. Primer sequences used were: miR-199a-5p, 5
0 -GCGGCGGCCCAGTGTTCAGAC TA-3 0 and 5 0 -TGCAGGGTCCGAGGTAT-3 0 ; and U6, 5 0 -GCTTCGGCAG CACATATACTAAAAT-3 0 and 5 0 -CGCTTCACGAATTTGCGTGTCAT-3 0 . For qRT-PCR analysis, 35-40 blastocysts were sampled in each group. At least three independent experiments were performed. Data analysis was performed using the 2 -DDCt method.
Microinjection of miR-199a-5p Inhibitor or Mimic into Pronuclear Embryos
IVO pronuclear embryos were recovered from donors and placed in 50 ll of M2 medium droplets that were covered with mineral oil. To prevent excessive inhibition of miR-199a-5p, a moderate injection dose was determined based on a preliminary experiment by injecting the miR-199a-5p inhibitor at different concentrations. A total of 7 pl of the miR-199a-5p inhibitor (Ribobio) or a negative control fragment of the miRNA inhibitor at a concentration of 50 nM was microinjected into the cytoplasm of IVO pronuclear embryos. After incubation at 378C for 15 min, injected IVO embryos were transferred to the oviducts of pseudopregnant female mice for further development. Blastocysts of similar morphology were collected from these females, and a portion of the blastocysts were transferred to the uterine horns of recipients for further development, with six embryos in each uterine horn. MiR-199a-5p inhibitor is the anti-sense strand of miR-199a-5p (5 0 -GAACAGGUAGUCUGAACA CUGGG-3 0 ) with 2 0 -O-methyl modification. The control inhibitor is 5 0 -ACGUGACACGUUCGGAGAAdTdT-3 0 with 2 0 -O-methyl modification. IVF pronuclear embryos were placed in 50 ll of M2 medium droplets that were covered with mineral oil. To prevent excessive overexpression of miR199a-5p, a moderate injection dose was determined based on a preliminary experiment by injecting the miR-199a-5p mimic at different concentrations. A total of 10 pl of the miR-199a-5p mimic (Ribobio) or a negative control fragment of the miRNA mimic at a concentration of 50 nM was microinjected into the cytoplasm of IVF pronuclear embryos. After incubation in M2 medium at 378C for 15 min, injected IVF embryos were washed and cultured in 
Immunofluorescence Staining
Immunofluorescence staining was performed as previously described [36] , with minor modifications. In both groups, blastocysts were randomly selected from three independent experimental replicates and fixed with 4% paraformaldehyde in PBS (Gibco BRL) at 48C for 1 h and then permeabilized with PBS/ 0.5% Triton X-100/0.1% PVA (PBST-PVA) at room temperature for 1 h. After three washes with PBS/0.1% PVA at 378C for 10 min, the embryos were blocked in PBS/1% BSA at 48C for 6 h and then incubated with primary anti-CDX2 antibodies (1:200 dilution; Santa Cruz Biotechnology) and anti-POU5F1 antibodies (1:400 dilution; Santa Cruz Biotechnology) overnight at 48C. Following three washes with PBST-PVA, the embryos were incubated with secondary antibodies conjugated with Alexa Fluor 488 (anti-mouse; Invitrogen) and Alexa Fluor 594 (anti-rabbit; Invitrogen) for 1 h at room temperature. Finally, the samples were counterstained with 4 0 ,6-diamidino-2-phenylindole (Invitrogen), and then mounted onto a glass microscope slide in a drop of Vectashield mounting medium (Vector Laboratories), gently flattened with a coverslip, and visualized for cell counting. The fluorescence signals were determined using a confocal laser scanning microscope (Digital Eclipse C1; Nikon). Cell counting was performed either directly or from digital photographs.
Quantitation of Carbohydrate Metabolism
Carbohydrate levels were assayed by using the ultramicrofluorimetry technique, using coupled enzyme-based reactions [37] [38] [39] . Briefly, blastocysts were randomly selected from three independent experimental replicates. Individual blastocysts were placed into 95.8-nl drops of 3-(N-morpholino) propanesulphonic acid (MOPS)-buffered G2 (Vitrolife AB) with human serum albumin (HSA) (Vitrolife AB) covered with paraffin oil, modified to contain 0.5 mM glucose as the sole carbohydrate source and incubated at 378C. Serial 1-nl samples of medium were taken every 30 min over a 1.5-h period, and concentrations of glucose and lactate in the same sample were assessed using independent assays as described in a previous study [37] [38] [39] , consisting of reagents for lactate assay (4.76 mM NAD þ , 100 U of lactate dehydrogenase/ml, and 2.6 mM EDTA in glycine-hydrazine buffer, pH 9.4) and reagents for glucose assay (3.7 mM MgSO 4 Á7H 2 O, 0.6 mM NADP þ , 0.5 mM ATP, 0.5 mM dithiothreitol, 12 U of hexokinase/ml, and 6 U of glucose-6-phosphate dehydrogenase/ml in EPPS buffer, pH 8.0).
The fluorescence of each droplet was measured in turn by exposing the pyridine nucleotides in the cocktail to the UV light source. Following this initial determination of fluorescence, a 1-nl sample was added to the reagent cocktail drop. Then, the fluorescence of the drops was determined. The change in fluorescence between the reagent cocktail drop before and after addition of the sample should be linear within the concentrations to be assessed. Once a linear standard curve has been achieved, the concentration of substrates from samples can be calculated from this standard. Glycolytic rate was expressed as the percentage of glucose converted to lactate and was calculated on the basis that 2 mol lactate is produced per mol of glucose glycolyzed by the embryo [39, 40] .
Statistical Analysis
All data are mean 6 standard deviation (SD) values. One-way analysis of variance (ANOVA) was used to compare differences among the groups, using SPSS version 20 software. A P value of ,0.05 was considered statistically significant.
RESULTS
General Profiling of Differentially Expressed miRNAs
At E3.5, 37 271 blastocysts in the IVO group and 38 394 blastocysts in the IVF group were sampled and pooled. In the IVO group, we used approximately 2200 donors to collect blastocysts. In the IVF group, the range of fertilization rate used to sample was 55%-65%, and the blastocyst rate (zygote to blastocyst) was 76.24% 6 4.28%. At E7.5, 822 epiblasts in the IVO group and 795 epiblasts in the IVF group were microRNA PROFILING IN IVF EMBRYOS sampled and pooled (Table 1) . To investigate genome-wide differences in miRNA expression between the two groups, miRNA-seq analyses were conducted. Also, these samples were used for methylated DNA immunoprecipitation sequencing (MeDIP-seq), as reported in another study [41] .
Compared with IVO groups, 123 miRNAs from the IVF group showed differential expression at E3.5, and 66 miRNAs from the IVF group showed differential expression at E7.5 (P , 0.05; FC . 2 or , 0.5) (Fig. 2A, Supplemental Table S1 ; all supplemental data are available online at www.biolreprod.org).
Among these differentially expressed miRNAs at E3.5, 23 miRNAs were upregulated, and 100 miRNAs were downregulated in the IVF group. At E7.5, 34 miRNAs were upregulated and 32 miRNAs were downregulated in the IVF group. (Fig.  2B ). Among these differentially expressed miRNAs, 13 miRNAs were consistently dysregulated at both E3.5 and E7.5, which accounted for 10.6% and 19.7% of differentially expressed miRNAs from E3.5 and E7.5, respectively. These differentially expressed miRNAs were mainly associated with the regulation of genes involved in carcinogenesis, genetic TAN ET AL.
information processing, glucose metabolism, and cytoskeleton organization (Fig. 2C) . Among the 13 consistently dysregulated miRNAs, miR199a-5p was consistently downregulated in the IVF group compared to the IVO group at both E3.5 and E7.5, which was further confirmed by miRNA qRT-PCR analysis (Fig. 3A) . It has been reported that miR-199a-5p directly targets the 3 0 -untranslated region of Hk2 mRNA [42] , which encodes hexokinase 2 (HK2), an enzyme that catalyzes the irreversible first step of glycolysis [43] . As confirmed by qRT-PCR, the expression of Hk2 was consistently upregulated in the IVF group at both E3.5 and E7.5 (Fig. 3B) .
IVF Blastocysts Show Higher Glycolytic Rate, Cell Lineage Misallocation, and Lower Fetal Survival Post Implantation
The rate of glucose consumption by IVF blastocysts was significantly lower than that of IVO blastocysts (15.9 6 1.3 vs. microRNA PROFILING IN IVF EMBRYOS 21.1 6 1.2 pmol/embryo/h, respectively; P , 0.05) (Fig. 4A) . In contrast, the rate of lactate production by IVF blastocysts was significantly higher than that of IVO blastocysts (21.1 6 1.8 vs. 17.7 6 1.1 pmol/embryo/h, respectively; P , 0.05) (Fig. 4A) . When expressed as a glycolytic rate, based on the assumption that 1 mol glucose produces 2 mol lactate [44] , IVF blastocysts exhibited a significantly higher glycolytic rate (percentage of glucose converted to lactate) than in IVO blastocysts (66.1 6 6.4% vs. 41.8 6 3.2%, respectively; P , 0.05) (Fig. 4B) . In addition, the number of inner cell mass (ICM) cells was significantly lower in IVF blastocysts than that in IVO blastocysts (14.87 6 2.21 vs. 17.45 6 2.10, respectively; P , 0.05), and the number of trophectoderm
; P , 0.05). IVF blastocysts had a significantly decreased ICM-to-TE (ICM/TE) cell ratio compared to that in IVO blastocysts (0.42 6 0.08 vs. 0.54 6 0.09, respectively; P , 0.05) (Fig. 4C) , although the total cell number of IVO and IVF blastocysts was comparable (49.9 6 1.5 vs. 50.7 6 2.6, respectively; P . 0.05).
Following transfer of blastocysts to pseudopregnant recipients, no significant differences in implantation rate between the IVO and IVF groups were observed. However, significantly fewer IVF fetuses survived than IVO fetuses (6.20 6 0.95 vs. 7.89 6 0.89, respectively; P , 0.05) ( Table 2) .
MiR-199a-5p Downregulation Causes Cell Lineage Misallocation and Lower Fetal Survival Post Implantation
Next, we asked whether the downregulation of miR-199a-5p was responsible for the higher glycolytic rate and lower developmental potential of IVF blastocysts. Downregulation of miR-199a-5p (Fig. 5A ) in IVO embryos increased the expression of Hk2 compared to the negative control (Fig.  5B) . As expected, downregulation of miR-199a-5p resulted in a significantly higher glycolytic rate than in the negative control (65.2 6 7.0% vs. 47.0 6 3.6%, respectively; P , 0.05) (Fig. 5C ). In addition, downregulation of miR-199a-5p significantly decreased the ICM/TE ratio compared to the control blastocysts (0.45 6 0.07 vs. 0.54 6 0.07, respectively; TAN ET AL.
P , 0.05) (Fig. 5D) . Following blastocyst transfer, downregulation of miR-199a-5p significantly reduced the number of fetuses that survived compared to the control (6.50 6 1.04 vs. 7.75 6 0.66, respectively; P , 0.05) (Fig. 5E ).
On the other hand, overexpression of miR-199a-5p (Fig.  6A ) in IVF embryos reduced the expression of Hk2 (Fig. 6B ) and the glycolytic rate compared with that in the negative control (50.1 6 5.3% vs. 68.3 6 6.8%, respectively; P , 0.05) (Fig. 6C) . In addition, overexpression of miR-199a-5p in IVF embryos restored the ICM/TE ratio (0.50 6 0.08 vs. 0.42 6 0.08, respectively; P , 0.05) (Fig. 6D ) comparable to that in IVO blastocysts (0.54 6 0.09). Following blastocyst transfer, overexpression of miR-199a-5p significantly increased the number of surviving fetuses compared to that in the control (7.23 6 0.97 vs. 6.27 6 1.05, respectively; P , 0.05) (Fig.  6E) .
DISCUSSION
MiRNAs are a class of regulatory molecules that function in RNA silencing and posttranscriptional regulation of gene expression [45] . Since the first miRNA identification in Caenorhabditis elegans [46] , thousands of miRNAs have now been characterized. More importantly, each miRNA may have a broad range of target mRNAs, based on their sequence homology. Therefore, expression changes of even a single miRNA could have detrimental impacts on diverse cellular activities that are regulated by the product of these genes [47] .
Indeed, miRNAs are now recognized as major regulators of gene expression with crucial functions in numerous biological processes, including: development, proliferation, differentiation, apoptosis, and the stress response, as well as in the initiation and progression of various diseases [45, 48, 49] .
In the current study, we performed a comparative miRNA profiling between IVO and IVF mouse embryos at E3.5 and E7.5. We found that the consistently dysregulated miRNAs were mainly associated with the regulation of genes involved in carcinogenesis, genetic information processing, glucose metabolism, and cytoskeleton organization. These alterations may contribute to the IVF-associated adverse outcomes. For example, many studies have shown that IVF has a profound effect on DNA methylation, gene expression pattern, posttranscription translation, and posttranslational process [29, [50] [51] [52] and that this aberrant genetic information processing can lead to compromised fetal growth or even embryonic lethality. In addition, previous studies indicate that the glucose metabolism is altered in IVF offspring [53, 54] , with IVF children showing increased fasting glucose levels, triglyceride levels, adiposity, and systemic and pulmonary vascular dysfunction [55] [56] [57] . Moreover, our previous study showed that actin cytoskeleton disorganization is vital for the impaired development of IVF preimplantation embryos [58] . Therefore, dysregulated miRNAs may disrupt these processes, leading to the adverse outcomes of IVF. 
microRNA PROFILING IN IVF EMBRYOS
We found that miR-199a-5p was consistently downregulated in the IVF group compared to that in the IVO group at E3.5 and E7.5. MiR-199a, as an evolutionarily conserved small RNA, was first found to be spatiotemporally expressed in the mouse uterus during implantation [17] . Since then, numerous reports have shown that the dysregulation (downor upregulation) of miR-199a-5p, one mature form of miR199a, is implicated in various tumor types, including acute myeloid leukemia [59] , ovarian cancer [60] , gastric cancer [61] , hepatocellular carcinoma invasion [62] , and breast tumors [63] . Studies indicate that miR-199a-5p is a putative tumor suppressor in human liver and testicular cancer cells [62, 64] . Recently, miR-199a-5p was shown to directly target the 3 0 -untranslated region of Hk2, which encodes an enzyme that catalyzes the irreversible first step of glycolysis, in liver cancer cells [42] . As a proportion of IVF blastocysts have an abnormally elevated levels of glycolysis [44] , which may be linked to the lower developmental potential and subsequent viability of IVF embryos [39] , this led us to hypothesize that the downregulation of miR-199a-5p in IVF blastocysts is responsible for the higher glycolytic rate, lower developmental potential, and subsequent viability of IVF embryos. By microinjecting a miR-199a-5p mimic or a specific inhibitor into the IVF or IVO embryos, we confirmed that the downregulation of miR-199a-5p in IVF blastocysts is responsible for the lower developmental potential and subsequent viability. However, whether this effect occurs due to an increased rate of glycolysis is difficult to determine for the following reasons. First, miR-199a-5p targets a broad range of mRNAs, such as glycerol phosphate dehydrogenase 2, mitochondrial (Gpd2), discoidin domain receptor family, member 1 (Ddr1), hypoxia inducible factor 1, alpha subunit (Hif1a), karyopherin (importin) beta 1 (Kpnb1), and nemolike kinase (Nlk), and these genes are also important for periimplantation development. Second, glycolysis in early embryos occurs in a spatiotemporal manner [44, 65] , and it is difficult to control the spatiotemporal patterns using current technologies. Third, previous study showed that the Hk2 knockdown caused a G 1 phase cell cycle arrest through regulating phosphorylation of CDK2 [66] . Therefore, the underlying mechanism of miR-199a-5p in affecting the development of peri-implantation embryos requires further exploration.
In conclusion, the results of this study further underline the important roles played by miRNAs in mediating changes in gene expression occurring during implantation and early postimplantation development. In particular, our results confirm that miR-199a-5p downregulation is responsible for the lower developmental potential and subsequent viability. We anticipate that strategies preventing the downregulation of miR-199a-5p may represent a new effective strategy for improving the development of IVF peri-implantation embryos.
